DNA Repair and Human Health 2011
DOI: 10.5772/22946
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant Viral Vectors for Investigating DNA Damage Responses and Gene Therapy of Xeroderma Pigmentosum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 104 publications
(114 reference statements)
0
1
0
Order By: Relevance
“…Later the same group showed that these T4N5 liposomes can be delivered through the skin in a 1 % hydrogel lotion, efficiently removing CPD lesions present in the epidermis and consequently reducing UV-induced mutagenesis. Clinical trials showed that this enzyme was efficient in XP patients, reducing 30 % of the BCC rate, reviewed in (121). A sunscreen with enveloped T4 endo V is now being produced by a Japanese company (Synergy Worldwide) and is sold in some countries.…”
Section: General Considerationsmentioning
confidence: 99%
“…Later the same group showed that these T4N5 liposomes can be delivered through the skin in a 1 % hydrogel lotion, efficiently removing CPD lesions present in the epidermis and consequently reducing UV-induced mutagenesis. Clinical trials showed that this enzyme was efficient in XP patients, reducing 30 % of the BCC rate, reviewed in (121). A sunscreen with enveloped T4 endo V is now being produced by a Japanese company (Synergy Worldwide) and is sold in some countries.…”
Section: General Considerationsmentioning
confidence: 99%